HK1202243A1 - 改善認知功能和降低心率的方法 - Google Patents

改善認知功能和降低心率的方法

Info

Publication number
HK1202243A1
HK1202243A1 HK15102730.4A HK15102730A HK1202243A1 HK 1202243 A1 HK1202243 A1 HK 1202243A1 HK 15102730 A HK15102730 A HK 15102730A HK 1202243 A1 HK1202243 A1 HK 1202243A1
Authority
HK
Hong Kong
Prior art keywords
methods
heart rate
cognitive function
improving cognitive
decreasing heart
Prior art date
Application number
HK15102730.4A
Other languages
English (en)
Inventor
‧尤科-毛羅
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of HK1202243A1 publication Critical patent/HK1202243A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
HK15102730.4A 2009-02-02 2015-03-17 改善認知功能和降低心率的方法 HK1202243A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14931009P 2009-02-02 2009-02-02
US18354809P 2009-06-02 2009-06-02

Publications (1)

Publication Number Publication Date
HK1202243A1 true HK1202243A1 (zh) 2015-09-25

Family

ID=42041547

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102730.4A HK1202243A1 (zh) 2009-02-02 2015-03-17 改善認知功能和降低心率的方法

Country Status (8)

Country Link
US (2) US20100203123A1 (zh)
EP (2) EP2391361A1 (zh)
JP (5) JP2012516852A (zh)
CN (3) CN104042600A (zh)
AU (2) AU2016201382A1 (zh)
CA (1) CA2751275A1 (zh)
HK (1) HK1202243A1 (zh)
WO (1) WO2010088700A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
EP2709611A4 (en) * 2011-05-19 2014-10-29 Univ California THERAPEUTIC FOOD AGAINST COGNITIVE REMOVAL
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20130084272A1 (en) * 2011-09-29 2013-04-04 Philippe Perrin Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
CA2903599A1 (en) * 2013-03-15 2014-09-18 Genspera, Inc. Methods for making cancer compositions
KR102615285B1 (ko) 2013-12-20 2023-12-19 마라 리뉴어블즈 코퍼레이션 미생물로부터 오일을 회수하는 방법
TR201503136A2 (tr) * 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
JP7101087B2 (ja) * 2018-09-05 2022-07-14 株式会社 伊藤園 軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) * 2019-02-22 2021-05-21 Microphyt Complement alimentaire
WO2021022340A1 (en) * 2019-08-08 2021-02-11 Swinburne University Of Technology Uses of long-chain polyunsaturated fatty acids
EP4278190A1 (en) * 2021-01-15 2023-11-22 Cambridge Cognition Limited Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
ATE446101T1 (de) * 1993-06-09 2009-11-15 Martek Biosciences Corp Verwendung von docosahexaensäure zur herstellung eines arzneimittels zur behandlung der senilen demenz und alzheimer-erkrankung
ES2135756T3 (es) 1994-08-16 1999-11-01 Frische Gmbh Procedimiento para la obtencion de productos nativos no solubles en agua a partir de mezclas de sustancias con ayuda de la fuerza centrifuga.
EP0823475B1 (en) * 1995-04-17 2009-06-17 National Institute of Advanced Industrial Science and Technology Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 （ｎ−６）系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
US6399803B1 (en) 1999-02-26 2002-06-04 Omegatech, Inc. Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides
WO2001051598A1 (en) 2000-01-11 2001-07-19 Monsanto Technology Llc Process for making an enriched mixture of polyunsaturated fatty acid esters
EP2295594B1 (en) 2000-01-19 2018-04-04 DSM IP Assets B.V. Solventless extraction process
WO2001076385A1 (en) 2000-04-12 2001-10-18 Westfalia Separator Industry Gmbh Method for the fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation
JP4728561B2 (ja) 2001-05-14 2011-07-20 マーテック バイオサイエンシーズ コーポレーション 植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法
MX281182B (es) 2001-05-14 2010-11-22 Martek Biosciences Boulder Corp Produccion y uso de una fraccion rica en lipidos polares, que contienen acidos grasos altamente insaturados omega-3 y/u omega-6, procedentes de microbios, de semillas de plantas y de organismos marinos geneticamente modificados.
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
EP2266525B1 (en) 2002-05-03 2012-07-11 Martek Biosciences Corporation High quality lipids and methods for producing by enzymatic liberation from biomass
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
WO2006077495A1 (en) * 2005-01-24 2006-07-27 Pronova Biocare As Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
EP1888081B1 (en) * 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
RU2444356C2 (ru) * 2005-07-08 2012-03-10 Мартек Байосайенсиз Корпорейшн Полиненасыщенные жирные кислоты для лечения деменции и состояний, связанных с преддеменцией
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
US20090023808A1 (en) 2007-06-29 2009-01-22 Martek Biosciences Corporation Production and Purification of Esters of Polyunsaturated Fatty Acids
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid

Also Published As

Publication number Publication date
CN104042600A (zh) 2014-09-17
WO2010088700A1 (en) 2010-08-05
CN102365087A (zh) 2012-02-29
JP2022059063A (ja) 2022-04-12
EP2939671A1 (en) 2015-11-04
US20130172412A1 (en) 2013-07-04
AU2010207929A1 (en) 2011-09-22
US20100203123A1 (en) 2010-08-12
EP2391361A1 (en) 2011-12-07
JP2012516852A (ja) 2012-07-26
AU2017245327A1 (en) 2017-11-02
JP2020050675A (ja) 2020-04-02
CN108324706A (zh) 2018-07-27
CA2751275A1 (en) 2010-08-05
AU2016201382A1 (en) 2016-03-24
JP2018104477A (ja) 2018-07-05
JP2015143248A (ja) 2015-08-06

Similar Documents

Publication Publication Date Title
HK1202243A1 (zh) 改善認知功能和降低心率的方法
GB2494493B (en) Patient interface and aspects thereof
GB2509641B (en) Patient interface and aspects thereof
GB2530686B (en) Patient interface and headgear
EP2611496A4 (en) Methods of Treatment
EP2556799A4 (en) PROCESS FOR PRODUCING TISSUE CLIPS, AND CLIPPER FOR TISSUE
EP2561072A4 (en) NANOZYMES, PROCESSES FOR PRODUCING NANOZYMES, AND METHODS OF USING NANOZYMES
EP2578153A4 (en) AUDIOMETER AND ASSOCIATED METHOD
GB0918392D0 (en) Diagnostic and therapeutic methods
IL214133A0 (en) Skin treatment
PT2630475T (pt) Método de diagnóstico e tratamento
GB0912744D0 (en) Methods and uses
EP2470022A4 (en) COMPOUNDS AND METHODS
GB2467764B (en) Attachment means and methods
GB0909380D0 (en) Method and use
EP2654742A4 (en) PROCESS FOR IMPROVING COGNITIVE FUNCTION
GB0903348D0 (en) Compounds and methods relating thereto
EP2496143A4 (en) HEART RATE MONITOR
EP2440238A4 (en) Methods of Treatment
IL220242A0 (en) Methods of improving cognitive functions
GB201013139D0 (en) An improved bed and bath
GB201008694D0 (en) An improved bed and bath
GB201018097D0 (en) Diagnostic method and treatment
GB0920904D0 (en) Uses and methods